| Nutrients | |
| The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation | |
| David Conen1  ThomasF. Lüscher2  GiovanniG. Camici2  Andrea Wiencierz3  Michael Coslovsky3  Pascal Meyre4  Stefan Osswald4  Stefanie Aeschbacher4  Michael Kühne4  Oliver Baretella5  Nicolas Rodondi5  Giulia Montrasio6  MartinF. Reiner6  NicoleR. Bonetti6  JürgH. Beer6  LeoH. Bonati7  Philipp Baumgartner8  Giorgio Moschovitis9  MarkG. Filipovic1,10  | |
| [1] Cardiovascular Research Institute Basel, University Hospital of Basel, 4031 Basel, Switzerland;Center for Molecular Cardiology, Laboratory for Platelet Research, University of Zurich, 8952 Schlieren, Switzerland;Clinical Trial Unit University Hospital of Basel, 4031 Basel, Switzerland;Department of Cardiology, University Hospital of Basel, 4031 Basel, Switzerland;Department of General Internal Medicine, Bern University Hospital, University of Bern, 3010 Bern, Switzerland;Department of Internal Medicine, Cantonal Hospital of Baden, 5404 Baden, Switzerland;Department of Neurology and Stroke Center, University Hospital Basel, University of Basel, 4031 Basel, Switzerland;Department of Neurology, University Hospital of Zurich, 8091 Zurich, Switzerland;Division of Cardiology, Ospedale Regionale di Lugano, 6900 Ticino, Switzerland;Institute of Anesthesiology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland; | |
| 关键词: atrial fibrillation; brain ischemia; eicosapentaenoic acid; omega-3 fatty acids; stroke; | |
| DOI : 10.3390/nu13020651 | |
| 来源: DOAJ | |
【 摘 要 】
The omega-3 fatty acid (n-3 FA) eicosapentaenoic acid (EPA) reduces stroke in patients with atherosclerotic cardiovascular disease. Whether EPA affects stroke or cerebral small vessel dis-ease in patients with atrial fibrillation (AF) remains uncertain. EPA, docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), and alpha-linolenic acid (ALA) were determined by gas chromatography in 1657 AF patients from the Swiss Atrial Fibrillation study. All patients underwent brain MRI to detect ischemic brain infarcts, classified as large noncortical or cortical infarcts (LNCCIs); markers of small vessel disease, classified as small noncortical infarcts (SNCIs), number of microbleeds, and white matter lesion (WML) volumes. Individual and total n-3 FAs (EPA + DHA + DPA + ALA) were correlated with LNCCIs and SNCIs using logistic regression, with numbers of microbleeds using a hurdle model, and WML volumes using linear regression. LNCCIs were detected in 372 patients (22.5%). EPA correlated inversely with the prevalence of LNCCIs (odds ratio [OR] 0.51 per increase of 1 percentage point EPA, 95% confidence interval [CI] 0.29–0.90). DPA correlated with a higher LNCCI prevalence (OR 2.48, 95%CI 1.49–4.13). No associations with LNCCIs were found for DHA, ALA, and total n-3 FAs. Neither individual nor total n-3 FAs correlated with markers of small vessel disease. In conclusion, EPA correlates inversely with the prevalence of ischemic brain infarcts, but not with markers of small vessel disease in patients with AF.
【 授权许可】
Unknown